Amneal Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $3.94B
Liabilities Breakdown FY2021
Total Liabilities: $3.58B
Asset Breakdown
Total Assets: $3.94B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $247.8M | 6.3% |
| Accounts Receivable | $662.6M | 16.8% |
| Inventory | $489.4M | 12.4% |
| Property, Plant & Equipment | $514.2M | 13.1% |
| Goodwill | $593.0M | 15.1% |
| Intangible Assets | $1.17B | 29.6% |
| Other Assets | $265.8M | 6.7% |
Liabilities Breakdown
Total Liabilities: $3.58B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $131.1M | 3.7% |
| Long-Term Debt | $2.68B | 74.9% |
| Other Liabilities | $768.2M | 21.5% |